SCBio (Drug Discovery) Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
32
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$10.1M
- Investors
-
25
SCBio (Drug Discovery) General Information
Description
Operator of a pharmaceutical company intended to focus on making drugs to improve well-being. The company's services include discovering and developing novel therapeutics, leading innovations for future medicine, offering timely services for product selection, and launching strategies, and supply mitigation, providing patients with access to medicines with specialized technologies in immuno-oncology.
Contact Information
Website
www.sc-bio.co.krCorporate Office
- 94-14 Techno 2
- Yuseong
- Daejeon, 34014
- South Korea
Corporate Office
- 94-14 Techno 2
- Yuseong
- Daejeon, 34014
- South Korea
SCBio (Drug Discovery) Timeline
SCBio (Drug Discovery) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC (Series B) | 31-Aug-2025 | $10.1M | Completed | Generating Revenue | ||
| 3. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 2. Early Stage VC (Series A) | 17-May-2023 | $8.26M | $12.8M | Completed | Generating Revenue | |
| 1. Seed Round | 23-Aug-2022 | $4.57M | $4.57M | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
SCBio (Drug Discovery) Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
SCBio (Drug Discovery) Investors (25)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Enlight Ventures | Venture Capital | Minority | ||
| Hyundai Technology Investment | Venture Capital | Minority | ||
| Kolon Investment | Venture Capital | Minority | ||
| Korea Development Bank | VC-Backed Company | Minority | ||
| Pioneer Investment | Corporate Venture Capital | Minority |
SCBio (Drug Discovery) FAQs
-
When was SCBio (Drug Discovery) founded?
SCBio (Drug Discovery) was founded in 2021.
-
Where is SCBio (Drug Discovery) headquartered?
SCBio (Drug Discovery) is headquartered in Daejeon, South Korea.
-
What is the size of SCBio (Drug Discovery)?
SCBio (Drug Discovery) has 32 total employees.
-
What industry is SCBio (Drug Discovery) in?
SCBio (Drug Discovery)’s primary industry is Drug Discovery.
-
Is SCBio (Drug Discovery) a private or public company?
SCBio (Drug Discovery) is a Private company.
-
What is SCBio (Drug Discovery)’s current revenue?
The current revenue for SCBio (Drug Discovery) is .
-
How much funding has SCBio (Drug Discovery) raised over time?
SCBio (Drug Discovery) has raised $22.9M.
-
Who are SCBio (Drug Discovery)’s investors?
Enlight Ventures, Hyundai Technology Investment, Kolon Investment, Korea Development Bank, and Pioneer Investment are 5 of 25 investors who have invested in SCBio (Drug Discovery).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
